Literature DB >> 15957607

Pattern VEP is a useful technique in monitoring the effectiveness of occlusion therapy in amblyopic eyes under occlusion therapy.

Ayse Oner1, Mesut Coskun, Cem Evereklioglu, Hakki Dogan.   

Abstract

PURPOSE: To evaluate the effectiveness and clinical significance of pattern visual evoked potential (P-VEP) parameters on visual acuity in amblyopic patients under occlusion therapy.
METHODS: A total of 34 consecutive children with anisometropic amblyopia were included in this study. All patients underwent a full initial ophthalmologic and orthoptic evaluation. P-VEP test was performed in all cases and binocular vision was tested and recorded with Worth's four-dot test and Bagolini striated glasses at each visit. Part-time occlusion therapy was performed by using adhesive patches.
RESULTS: The mean (+/- SEM) cycloplegic refractive error was + 5.6 +/- 0.6 diopters (D) in the amblyopic eyes and + 1.8 +/- 0.2 D in the normal eye. The mean levels of best-corrected visual acuity were statistically differed between each measurement for occlusion therapy (for each, p < 0.05). The ratio of the patients with binocular vision increased after 6 months occlusion therapy and the difference was statistically significant (p < 0.05). In addition, P100 amplitude improved at each visit and the difference was significant when compared with baseline values (for each, p < 0.05).
CONCLUSIONS: P100 amplitude of the P-VEP test parallels the improvement in subjective visual acuity in amblyopic eyes under occlusion therapy. Therefore, this test may be useful in monitoring the visual acuity in the preverbal or non-verbal patched patients.

Entities:  

Mesh:

Year:  2004        PMID: 15957607     DOI: 10.1007/s10633-004-7098-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  22 in total

1.  High resolution fMRI of ocular dominance columns within the visual cortex of human amblyopes.

Authors:  Bradley G Goodyear; David A Nicolle; Ravi S Menon
Journal:  Strabismus       Date:  2002-06

2.  Visual evoked potentials standard (2004).

Authors:  J Vernon Odom; Michael Bach; Colin Barber; Mitchell Brigell; Michael F Marmor; Alma Patrizia Tormene; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

3.  Visually evoked cortical responses of amblyopes to a spatially alternating stimulus.

Authors:  S Sokol; B Bloom
Journal:  Invest Ophthalmol       Date:  1973-12

4.  Pattern ERG in amblyopia.

Authors:  G B Arden; S L Wooding
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-01       Impact factor: 4.799

5.  Electro-oculographic abnormalities in amblyopia.

Authors:  C Williams; D Papakostopoulos
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

6.  The effect of reading and near-work on the development of myopia in emmetropic boys: a prospective, controlled, three-year follow-up study.

Authors:  I F Hepsen; C Evereklioglu; H Bayramlar
Journal:  Vision Res       Date:  2001-09       Impact factor: 1.886

7.  Prevalence and causes of amblyopia in an adult population.

Authors:  K Attebo; P Mitchell; R Cumming; W Smith; N Jolly; R Sparkes
Journal:  Ophthalmology       Date:  1998-01       Impact factor: 12.079

8.  The course of moderate amblyopia treated with patching in children: experience of the amblyopia treatment study.

Authors: 
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

9.  Decreased activation of the lateral geniculate nucleus in a patient with anisometropic amblyopia demonstrated by functional magnetic resonance imaging.

Authors:  Atsushi Miki; Grant T Liu; Zachariah G Goldsmith; Chia-Shang J Liu; John C Haselgrove
Journal:  Ophthalmologica       Date:  2003 Sep-Oct       Impact factor: 3.250

10.  Amblyopia: a long-term follow-up.

Authors:  J C Sparrow; J T Flynn
Journal:  J Pediatr Ophthalmol       Date:  1977 Nov-Dec
View more
  8 in total

1.  Steady-state contrast response functions provide a sensitive and objective index of amblyopic deficits.

Authors:  Daniel H Baker; Mathieu Simard; Dave Saint-Amour; Robert F Hess
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-29       Impact factor: 4.799

2.  Visual acuity evaluated by pattern-reversal visual-evoked potential is affected by check size/visual angle.

Authors:  Xiping Chen; Qianqian Li; Xiaoqin Liu; Li Yang; Wentao Xia; Luyang Tao
Journal:  Neurosci Bull       Date:  2012-12-07       Impact factor: 5.203

3.  Comparison of the efficacies of patching and penalization therapies for the treatment of amblyopia patients.

Authors:  Cemalettin Cabi; Isil Bahar Sayman Muslubas; Ayse Yesim Aydin Oral; Metin Dastan
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

4.  The reproducibility of binocular pattern reversal visual evoked potentials: a single subject design.

Authors:  Tessa B Mellow; Alki Liasis; Ruth Lyons; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2011-03-25       Impact factor: 2.379

5.  Pattern visual evoked potential as a predictor of occlusion therapy for amblyopia.

Authors:  Woosuk Chung; Samin Hong; Jong Bok Lee; Sueng-Han Han
Journal:  Korean J Ophthalmol       Date:  2008-12

6.  Characterising the orientation-specific pattern-onset visual evoked potentials in children with bilateral refractive amblyopia and non-amblyopic controls.

Authors:  Tiong Peng Yap; Chi D Luu; Catherine M Suttle; Audrey Chia; Mei Ying Boon
Journal:  Doc Ophthalmol       Date:  2020-09-23       Impact factor: 2.379

7.  Comparison of the Wave Amplitude of Visually Evoked Potential in Amblyopic Eyes between Patients with Esotropia and Anisometropia and a Normal Group.

Authors:  Mohammad Reza Talebnejad; Saeedeh Hosseinmenni; Ebrahim Jafarzadehpur; Ali Mirzajani; Enayatollah Osroosh
Journal:  Iran J Med Sci       Date:  2016-03

8.  Fractal Dimension Analysis of Transient Visual Evoked Potentials: Optimisation and Applications.

Authors:  Mei Ying Boon; Bruce Ian Henry; Byoung Sun Chu; Nour Basahi; Catherine May Suttle; Chi Luu; Harry Leung; Stephen Hing
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.